BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 16469749)

  • 1. Individual Timp deficiencies differentially impact pro-MMP-2 activation.
    English JL; Kassiri Z; Koskivirta I; Atkinson SJ; Di Grappa M; Soloway PD; Nagase H; Vuorio E; Murphy G; Khokha R
    J Biol Chem; 2006 Apr; 281(15):10337-46. PubMed ID: 16469749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential inhibition of membrane type 3 (MT3)-matrix metalloproteinase (MMP) and MT1-MMP by tissue inhibitor of metalloproteinase (TIMP)-2 and TIMP-3 rgulates pro-MMP-2 activation.
    Zhao H; Bernardo MM; Osenkowski P; Sohail A; Pei D; Nagase H; Kashiwagi M; Soloway PD; DeClerck YA; Fridman R
    J Biol Chem; 2004 Mar; 279(10):8592-601. PubMed ID: 14681236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular activation of MMP-2 (gelatinase A) by MT2-MMP occurs via a TIMP-2-independent pathway.
    Morrison CJ; Butler GS; Bigg HF; Roberts CR; Soloway PD; Overall CM
    J Biol Chem; 2001 Dec; 276(50):47402-10. PubMed ID: 11584019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of tissue inhibitor of metalloproteinases-2 (TIMP-2) in regulation of pro-gelatinase A activation catalyzed by membrane-type matrix metalloproteinase-1 (MT1-MMP) in human cancer cells.
    Shofuda K; Moriyama K; Nishihashi A; Higashi S; Mizushima H; Yasumitsu H; Miki K; Sato H; Seiki M; Miyazaki K
    J Biochem; 1998 Aug; 124(2):462-70. PubMed ID: 9685743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tissue inhibitor of metalloproteinases-4 inhibits but does not support the activation of gelatinase A via efficient inhibition of membrane type 1-matrix metalloproteinase.
    Bigg HF; Morrison CJ; Butler GS; Bogoyevitch MA; Wang Z; Soloway PD; Overall CM
    Cancer Res; 2001 May; 61(9):3610-8. PubMed ID: 11325829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Domain interactions in the gelatinase A.TIMP-2.MT1-MMP activation complex. The ectodomain of the 44-kDa form of membrane type-1 matrix metalloproteinase does not modulate gelatinase A activation.
    Overall CM; Tam E; McQuibban GA; Morrison C; Wallon UM; Bigg HF; King AE; Roberts CR
    J Biol Chem; 2000 Dec; 275(50):39497-506. PubMed ID: 10991943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of tissue inhibitor of metalloproteinases-2 effect on pro-matrix metalloproteinase-2 activation by membrane-type 1 matrix metalloproteinase using baculovirus/insect-cell expression system.
    Jo Y; Yeon J; Kim HJ; Lee ST
    Biochem J; 2000 Feb; 345 Pt 3(Pt 3):511-9. PubMed ID: 10642509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Claudin promotes activation of pro-matrix metalloproteinase-2 mediated by membrane-type matrix metalloproteinases.
    Miyamori H; Takino T; Kobayashi Y; Tokai H; Itoh Y; Seiki M; Sato H
    J Biol Chem; 2001 Jul; 276(30):28204-11. PubMed ID: 11382769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective involvement of TIMP-2 in the second activational cleavage of pro-MMP-2: refinement of the pro-MMP-2 activation mechanism.
    Lafleur MA; Tester AM; Thompson EW
    FEBS Lett; 2003 Oct; 553(3):457-63. PubMed ID: 14572669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sequence motifs of tissue inhibitor of metalloproteinases 2 (TIMP-2) determining progelatinase A (proMMP-2) binding and activation by membrane-type metalloproteinase 1 (MT1-MMP).
    Worley JR; Thompkins PB; Lee MH; Hutton M; Soloway P; Edwards DR; Murphy G; Knäuper V
    Biochem J; 2003 Jun; 372(Pt 3):799-809. PubMed ID: 12630911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TIMP-2 (tissue inhibitor of metalloproteinase-2) regulates MMP-2 (matrix metalloproteinase-2) activity in the extracellular environment after pro-MMP-2 activation by MT1 (membrane type 1)-MMP.
    Bernardo MM; Fridman R
    Biochem J; 2003 Sep; 374(Pt 3):739-45. PubMed ID: 12755684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of the AB loop region of TIMP-2. Involvement in pro-MMP-2 activation.
    Rapti M; Knaüper V; Murphy G; Williamson RA
    J Biol Chem; 2006 Aug; 281(33):23386-94. PubMed ID: 16777853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression and activation of matrix metalloproteinase-2 (MMP-2) and its co-localization with membrane-type 1 matrix metalloproteinase (MT1-MMP) correlate with melanoma progression.
    Hofmann UB; Westphal JR; Zendman AJ; Becker JC; Ruiter DJ; van Muijen GN
    J Pathol; 2000 Jul; 191(3):245-56. PubMed ID: 10878545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TIMP independence of matrix metalloproteinase (MMP)-2 activation by membrane type 2 (MT2)-MMP is determined by contributions of both the MT2-MMP catalytic and hemopexin C domains.
    Morrison CJ; Overall CM
    J Biol Chem; 2006 Sep; 281(36):26528-39. PubMed ID: 16825197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of integrin alpha(v)beta(3) correlates with activation of membrane-type matrix metalloproteinase-1 (MT1-MMP) and matrix metalloproteinase-2 (MMP-2) in human melanoma cells in vitro and in vivo.
    Hofmann UB; Westphal JR; Van Kraats AA; Ruiter DJ; Van Muijen GN
    Int J Cancer; 2000 Jul; 87(1):12-9. PubMed ID: 10861447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tissue inhibitor of metalloproteinase (TIMP)-2 acts synergistically with synthetic matrix metalloproteinase (MMP) inhibitors but not with TIMP-4 to enhance the (Membrane type 1)-MMP-dependent activation of pro-MMP-2.
    Toth M; Bernardo MM; Gervasi DC; Soloway PD; Wang Z; Bigg HF; Overall CM; DeClerck YA; Tschesche H; Cher ML; Brown S; Mobashery S; Fridman R
    J Biol Chem; 2000 Dec; 275(52):41415-23. PubMed ID: 10998420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Limited processing of pro-matrix metalloprotease-2 (gelatinase A) overexpressed by transfection in PC-3 human prostate tumor cells: association with restricted cell surface localization of membrane-type matrix metalloproteinase-1.
    Wilson MJ; Jiang A; Wiehr C; Wang X; Sinha AA; Pei D
    J Androl; 2004; 25(2):274-85. PubMed ID: 14760014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of matrix metalloproteinases (MMP-2, MMP-9, MT1-MMP) and their inhibitors (TIMP-1, TIMP-2) in common epithelial tumors of the ovary.
    Sakata K; Shigemasa K; Nagai N; Ohama K
    Int J Oncol; 2000 Oct; 17(4):673-81. PubMed ID: 10995877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. mRNA levels of membrane-type 1 matrix metalloproteinase (MT1-MMP), MMP-2, and MMP-9 and of their inhibitors TIMP-2 and TIMP-3 in normal thyrocytes and thyroid carcinoma cell lines.
    Hofmann A; Laue S; Rost AK; Scherbaum WA; Aust G
    Thyroid; 1998 Mar; 8(3):203-14. PubMed ID: 9545106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression and localization of matrix metalloproteinases (MT1-MMP, MMP-2) and tissue inhibitor of metalloproteinase-2 (TIMP-2) during synepitheliochorial placentation of goats (Capra hircus).
    Uekita T; Yamanouchi K; Sato H; Tojo H; Seiki M; Tachi C
    Placenta; 2004 Nov; 25(10):810-9. PubMed ID: 15451196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.